425: Strive CFO Reposts Semler Scientific Merger Update

Sentiment:

Communication Regarding Business Combination


Strive, Inc.'s CFO, Ben Pham, reposted a communication on X.com regarding the proposed business combination with Semler Scientific, Inc.

Capital raiseStrive intends to issue additional shares of its Class A common stock in connection with the proposed transaction.The Registration Statement on Form S-4 will register the Class A common stock to be issued by Strive.This issuance could lead to dilution for existing Strive shareholders.

Summary

  • A communication was reposted by Ben Pham, Chief Financial Officer of Strive, Inc., on X.com on September 30, 2025, concerning the proposed business combination with Semler Scientific, Inc.
  • The filing is a Form 425, filed by Strive, Inc., in connection with the proposed merger.
  • It includes a cautionary statement regarding forward-looking statements, outlining inherent risks and uncertainties associated with the transaction.
  • Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued in connection with the proposed transaction.
  • The Registration Statement will include an Information Statement/Proxy Statement/Prospectus, which will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
  • Information about participants in the solicitation of proxies, including directors and executive officers of both companies, will be detailed in the Information Statement/Proxy Statement/Prospectus.
  • The communication explicitly states it is not an offer to sell or a solicitation of an offer to sell or buy any securities.

Sentiment

Score: 6

Explanation: The filing confirms the ongoing process of the proposed business combination between Strive and Semler Scientific, indicating progress towards completion. However, it is primarily a cautionary statement detailing numerous risks and procedural information, without providing new positive financial or operational updates. The mention of potential dilution from stock issuance is a negative factor.

Positives

  • The proposed business combination aims for strategic and financial benefits, including an expected positive impact on the combined company's future financial performance.
  • The transaction is progressing with the intent to file necessary SEC documents, such as the Form S-4, indicating movement towards completion.

Negatives

  • Integration of the two companies may be more difficult, time-consuming, or costly than expected.
  • The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
  • Management's attention may be diverted from ongoing business operations and opportunities.
  • Potential for dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
  • Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships could occur.
  • Changes in Strive's or Semler Scientific's share price before closing are a possibility.

Risks

  • The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
  • The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
  • The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
  • The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
  • Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
  • General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the transaction and combined company.
  • The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
  • The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
  • The diversion of management's attention from ongoing business operations and opportunities.
  • Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
  • Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
  • Changes in Strive's or Semler Scientific's share price before closing.
  • Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The proposed transaction aims for strategic and financial benefits, including an expected positive impact on the combined company's future financial performance. However, these are forward-looking statements subject to significant risks and uncertainties, including integration challenges, market conditions, and regulatory changes, which could cause actual results to differ materially from anticipated results.

Management Comments

  • Ben Pham, Chief Financial Officer of Strive, Inc., reposted the communication on X.com on September 30, 2025, in connection with the proposed business combination.

Industry Context

This filing represents a procedural step in a proposed merger, which could reflect broader industry trends of consolidation or strategic repositioning. The explicit mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests a potential strategic direction or exposure for the combined entity, indicating an evolving landscape where digital assets play a role in corporate finance strategies.

Legal Proceedings

  • The filing mentions the possibility that legal proceedings may be instituted against Strive or Semler Scientific or the combined company as a risk factor associated with the proposed transaction.

Stakeholder Impact

  • Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock in connection with the proposed transaction.
  • Shareholders of Semler Scientific will be asked to approve the proposed transaction through a proxy solicitation.
  • Customers of both Strive and Semler Scientific may have adverse reactions or experience changes to business relationships as a result of the announcement or completion of the proposed transaction.
  • Employees of both Strive and Semler Scientific may have adverse reactions or experience changes to employee relationships as a result of the announcement or completion of the proposed transaction.

Next Steps

  • Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
  • The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
  • A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
  • Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with any other relevant documents filed with the SEC.

Key Dates

DateDescription
2024-12-31End of fiscal year for Semler Scientific's most recent annual report on Form 10-K.
2025-07-17Date Semler Scientific's definitive proxy statement for its 2025 Annual Meeting of Stockholders was filed with the SEC.
2025-09-12Date Strive's current report on Form 8-K was filed with the SEC.
2025-09-15Date Strive's current report on Form 8-K was filed with the SEC, containing information about directors and executive officers.
2025-09-30Date Ben Pham, CFO of Strive, Inc., reposted the communication on X.com.

Recommendation

hold

This filing is a procedural update on a proposed merger, not a financial results announcement. While it confirms the transaction is moving forward, it also highlights significant risks and potential dilution from the issuance of new shares. Without new financial data or a clearer picture of the combined entity's prospects and synergies, a 'hold' recommendation is appropriate for existing investors, awaiting the full S-4 filing and more detailed financial projections. New investors should also 'hold' until more comprehensive information is available to assess the combined company's value and risks.

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Bitcoin Treasury, Digital Assets, Corporate Governance, Proxy Solicitation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.